✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Sequent Scientific Ltd.

SEQUENT

Market Cap
₹3,709 Cr.
P/E
318.44

Sequent Scientific Ltd.

About
SeQuent, an integrated pharmaceutical company founded in 2002, focuses on Animal Health (API and formulation) under the brand Alivira Animal Health. With a global footprint, SeQuent caters to livestoc… Read more
SeQuent, an integrated pharmaceutical company founded in 2002, focuses on Animal Health (API a… Read more
Low
92
52W Range
High
241
  • Sequent Scientific
  • Gufic Biosciences
  • Orchid Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
10 %
(as of Mar 19)
Source/Historic
Animal Healthcare - Market Share in Turkey
30 %
(as of Mar 19)
Source/Historic
Losartan - Market Share in USA
Revenue mix

Product Wise Break-Up

Segment Break-Up - Formulation Business-By Dosage

Segment Break-Up - Formulation Business-By Species Type

Location Wise Break-Up - Formulations

Location Wise Break-Up

Therapeutic Area Break-Up - Formulations

Customer Segment

Dosage Form Break-Up

R&D Break-Up - Product Wise

Asset Break-Up

Species Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Sequent Scientific Ltd. Business

    SeQuent, operating as Alivira Animal Health, is a global pharmaceutical company established in 2002. It focuses on developing products for livestock, poultry, and companion animals to create value in the animal health space.

    Sequent Scientific major competitors are Gufic Biosciences, Orchid Pharma, Panacea Biotec, Guj. Themis Biosyn, Unichem Lab, Zota Health Care, Indoco Remedies.
    Market Cap of Sequent Scientific is ₹3,709 Crs.
    While the median market cap of its peers are ₹3,177 Crs.

    Sequent Scientific seems to be less financially stable compared to its competitors.
    Altman Z score of Sequent Scientific is 4.33 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    Discussions & Analysis
    Sequent Scientific Ltd.
    Animal Healthcare & Sequent Scientific - Deep Dive - Scientific Investing
    Sequent | A Hidden Niche - SOIC
    Sequent Scientific | India’s Largest Pure-play Animal Health Company - Value Educator
    View the discussion on ValuePickr
    SequentScientific FY 2022 Annual Report Highlights - Value Educator
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material